Search - Institut Pasteur Access content directly

Filter your results

22 Results
Author: personID (integer) : 755798

The core-specific precursor T cell response is directed to the N-terminal and central parts of the protein and positively correlates to the viral load in chronically HCV-infected patients.

Geneviève Janvier , Marie Laure Chaix , Hélène Fontaine , Jean Louis Bresson , Stanislas Pol , et al.
Virology, 2005, 340 (2), pp.318-25. ⟨10.1016/j.virol.2005.06.031⟩
Journal articles pasteur-00013706v1
Image document

Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme

Christophe Hezode , Pascal Lebray , Victor de Ledinghen , Fabien Zoulim , Vincent Di Martino , et al.
Liver International, 2017, 37 (9), pp.1314 - 1324. ⟨10.1111/liv.13383⟩
Journal articles hal-01784615v1
Image document

Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort)

Melina Santos , Camelia Protopopescu , Elizabeth Delarocque‐astagneau , Marc Bourlière , Ventizlava Petrov‐sanchez , et al.
Liver International, 2021, Online ahead of print. ⟨10.1111/liv.15056⟩
Journal articles inserm-03465070v1
Image document

Social vulnerability of patients co-infected with hepatitis B and hepatitis delta viruses: Data from the ANRS CO22 HEPATHER cohort

Fabienne Marcellin , Fabrice Carrat , Clémence Ramier , Céline Dorival , Marta Lotto , et al.
Journal of Clinical Virology, 2021, 144, pp.104987. ⟨10.1016/j.jcv.2021.104987⟩
Journal articles inserm-03465047v2
Image document

Comparing interferon‐free with interferon‐based regimens in HCV patients: Rogers phenomenon and Simpson’s paradox

Fabrice Carrat , Pierre Nahon , Hélène Fontaine , Stanislas Pol , Gilles Hejblum
Journal of Viral Hepatitis, 2020, 27 (3), pp.329-332. ⟨10.1111/jvh.13225⟩
Journal articles hal-02437336v1
Image document

Liver fibrosis and all‐cause mortality in chronic HCV‐infected diabetic patients: A paradoxical association? (ANRS CO22 HEPATHER)

Tangui Barré , Clémence Ramier , Vincent Di Beo , Fabrice Carrat , Hélène Fontaine , et al.
Liver International, 2021, 41 (7), pp.1694 - 1698. ⟨10.1111/liv.14949⟩
Journal articles inserm-03332288v2
Image document

Hepatitis Delta virus in migrants: The challenge of elimination (ANRS CO22 HEPATHER cohort)

Marta Lotto , Hélène Fontaine , Fabienne Marcellin , Lauren Périères , Morgane Bureau‐stoltmann , et al.
Liver International, 2021, 42 (1), pp.249 - 252. ⟨10.1111/liv.15106⟩
Journal articles inserm-03648173v2
Image document

Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment

Arthur Berger , Federico Ravaioli , Oana Farcau , Davide Festi , Horia Stefanescu , et al.
Clinical Gastroenterology and Hepatology, 2021, 19 (4), pp.777-787.e17. ⟨10.1016/j.cgh.2020.06.022⟩
Journal articles hal-03258178v1
Image document

Effectiveness of direct‐acting antivirals for chronic hepatitis C treatment in migrant and non‐migrant populations in France

Tchadine Djaogol , Hélène Fontaine , Maël Baudoin , Camelia Protopopescu , Fabienne Marcellin , et al.
Liver International, 2021, 41 (10), pp.2328-2340. ⟨10.1111/liv.14823⟩
Journal articles inserm-03315468v2
Image document

Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort

Anne Laurain , Sophie Metivier , Georges Haour , Dominique Larrey , Céline Dorival , et al.
BMC Infectious Diseases, 2019, 19 (1), pp.300. ⟨10.1186/s12879-019-3923-5⟩
Journal articles hal-02120879v1
Image document

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment a prospective cohort study

Fabrice Carrat , Hélène Fontaine , Céline Dorival , Mélanie Simony , Alpha Diallo , et al.
The Lancet, 2019, 393 (10179), pp.1453-1464. ⟨10.1016/S0140-6736(18)32111-1⟩
Journal articles hal-02050395v1
Image document

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort

Karine Lacombe , Hélène Fontaine , Catherine Dhiver , Sophie Métivier , Eric Rosenthal , et al.
Journal of Acquired Immune Deficiency Syndromes - JAIDS, 2017, 75 (1), pp.97 - 107. ⟨10.1097/QAI.0000000000001342⟩
Journal articles hal-01778170v1
Image document

Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response

Jessica Azzi , Céline Dorival , Carole Cagnot , Hélène Fontaine , Clovis Lusivika-Nzinga , et al.
Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (6), pp.101923. ⟨10.1016/j.clinre.2022.101923⟩
Journal articles hal-03651922v1
Image document

Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation

Hélène Fontaine , Laurent Alric , Julien Labreuche , Benjamin Legendre , Alexandre Louvet , et al.
Journal of Hepatology, 2019, 70 (5), pp.831-838. ⟨10.1016/j.jhep.2018.12.036⟩
Journal articles hal-03366042v1
Image document

Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death

Mathieu Chalouni , Stanislas Pol , Philippe Sogni , Hélène Fontaine , Karine Lacombe , et al.
Journal of Hepatology, 2021, 74 (1), pp.37 - 47. ⟨10.1016/j.jhep.2020.08.008⟩
Journal articles inserm-03332406v2
Image document

Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study

Frédégonde About , Tiphaine Oudot-Mellakh , Jonathan Niay , Pascaline Rabiéga , Vincent Pedergnana , et al.
PLoS ONE, 2015, 10 (12), pp.e0145105. ⟨10.1371/journal.pone.0145105⟩
Journal articles hal-01257993v1
Image document

Predictive Factors for Hepatocellular Carcinoma in Chronic Hepatitis B Using Structural Equation Modeling: A Prospective Cohort Study

Laurent Lam , Hélène Fontaine , Marc Bourliere , Clovis Lusivika-Nzinga , Céline Dorival , et al.
Clinics and Research in Hepatology and Gastroenterology, 2021, 45 (5), pp.101713. ⟨10.1016/j.clinre.2021.101713⟩
Journal articles hal-03224103v1
Image document

Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage

Sabrina Cossais , Michaël Schwarzinger , Stanislas Pol , Hélène Fontaine , Dominique Larrey , et al.
PLoS ONE, 2019, 14 (5), pp.e0215596. ⟨10.1371/journal.pone.0215596⟩
Journal articles inserm-02263587v1
Image document

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

Georges‐philippe Pageaux , Clovis Lusivika Nzinga , Nathalie Ganne , Didier Samuel , Céline Dorival , et al.
BMC Infectious Diseases, 2022, 22 (1), pp.94. ⟨10.1186/s12879-022-07076-0⟩
Journal articles hal-03555553v1

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

Pierre Nahon , Valérie Bourcier , Richard Layese , Etienne Audureau , Carole Cagnot , et al.
Gastroenterology, 2017, 152 (1), pp.142-156.e2. ⟨10.1053/j.gastro.2016.09.009⟩
Journal articles hal-01447065v1

Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy

Philippe Sultanik , Vincent Mallet , Sylvie Lagaye , Armanda Casrouge , Céline Dorival , et al.
Liver International, 2015, 35 (7), pp.1833 - 1844. ⟨10.1111/liv.12759⟩
Journal articles istex pasteur-01380846v1
Image document

Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort)

Tangui Barré , Marie Libérée Nishimwe , Camelia Protopopescu , Fabienne Marcellin , Fabrice Carrat , et al.
Journal of Viral Hepatitis, 2020, 27 (12), pp.1473-1483. ⟨10.1111/jvh.13380⟩
Journal articles hal-03109215v1